The legacy of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued appeal as an investment. Initially a blockbuster success, generating vast revenues, generic competition has significantly eroded financial returns. While leading pharmaceutical firms hold patents on related therapies and inves

The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key markets has introduced considerable uncertainty . Investors are now assessing the effect of rival medications , dim